Morgan Stanley Reviews Biogen Earnings
April 24, 2015 at 09:56 AM EDT
In a report published Friday, analysts at Morgan Stanley maintained their Overweight rating on Biogen Inc (NASDAQ: BIIB). The company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.